Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524.
View in:
PubMed
subject areas
ADAM Proteins
ADAM Proteins
ADAMTS13 Protein
ADAMTS13 Protein
Adrenal Cortex Hormones
Adrenal Cortex Hormones
Adult
Adult
Antibodies, Monoclonal, Murine-Derived
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Antineoplastic Agents
Catheterization, Central Venous
Catheterization, Central Venous
Catheter-Related Infections
Catheter-Related Infections
Education, Medical, Continuing
Education, Medical, Continuing
Female
Female
Hemolytic-Uremic Syndrome
Hemolytic-Uremic Syndrome
Humans
Humans
Male
Male
Morbidity
Morbidity
Oklahoma
Oklahoma
Plasma Exchange
Plasma Exchange
Purpura, Thrombotic Thrombocytopenic
Purpura, Thrombotic Thrombocytopenic
Registries
Registries
Remission Induction
Remission Induction
Risk Factors
Risk Factors
Rituximab
Rituximab
Sepsis
Sepsis
authors with profiles
James N George
Sara Vesely